Search results
Results from the WOW.Com Content Network
The Blalock–Thomas–Taussig shunt (BTT shunt), [1] previously known as the Blalock–Taussig Shunt (BT shunt), [2] is a surgical procedure used to increase blood flow to the lungs in some forms of congenital heart disease [3] such as pulmonary atresia and tetralogy of Fallot, which are common causes of blue baby syndrome. [3]
The most common shunts are the Modified Blalock Taussig shunt (MBTS) or right ventricle- to pulmonary artery shunt (RVPA or Sano shunt). Most patients who undergo a Norwood procedure will proceed to further stages of single ventricle palliation. A second surgery, also known as the Glenn procedure, occurs at 4–6 months
The surgery had been designed and first performed on laboratory dogs by Thomas, who taught the technique to Blalock. Although Thomas perfected the technique, he could not perform the surgery because he was not a doctor. The surgery was not completely successful, since Eileen Saxon became cyanotic again a few months later. Another shunt was ...
He created, with assistance from his research and laboratory assistant Vivien Thomas and pediatric cardiologist Helen Taussig, the Blalock–Thomas–Taussig shunt, a surgical procedure to relieve the cyanosis from tetralogy of Fallot. [1] This operation ushered in the modern era of cardiac surgery.
This concept was applied in practice as a procedure known as the Blalock-Thomas-Taussig shunt. The procedure was developed by Alfred Blalock and Vivien Thomas, who were Taussig's colleagues at the Johns Hopkins Hospital. Taussig was partially deaf following an ear infection in childhood; in early adulthood this progressed to full deafness. [2]
This article will discuss what exactly a liver shunt is, how to recognize the signs of a liver shunt, what treatment options are available, and how to manage the disease. Read on to find out more!
After his second surgery, Caper had his medication increased. Today, he still suffers a few seizures a week, but usually not more than one a day. Throughout his journey, he has also been given a ...
"Treatment results that look impressive in small groups often vanish when larger groups are studied," The Washington Post editorial board wrote in a piece Sunday headlined, "Look to science, not ...